In this article, Joshua Fredell, Senior Vice President of Product Innovation, breaks down how GLP1 benefit decisions are shifting as demand heats up
The findings, published in the journal Diabetes, Obesity and Metabolism, provide real-world context to previous randomized clinical trials indicating that patients who stopped semaglutide (sold under the brand names Ozempic/Wegovy) and tirzepatide (sold under the brand names Mounjaro/Zepbound) regained more than half of the weight they lost within 12 months
Because compounded semaglutide sales hinge on the brand-name shortage, the clock is ticking down for the drugs
After two weeks of D-allulose treatment, sucrose-fed mice showed: Reduced belly fat accumulation Improved insulin sensitivity Better glucose control These benefits disappeared in mice lacking GLP-1 receptors, confirming GLP-1 is essential
Many patients prefer pellets because they eliminate daily dosing and maintain stable hormone levels, reducing symptoms more effectively throughout each day
At Total Skin Dermatology & Aesthetics our team of health experts can support your weight loss goals with tailored care and advanced treatments, whatever your goals may be